Related references
Note: Only part of the references are listed.AncPhore: A versatile tool for anchor pharmacophore steered drug discovery with applications in discovery of new inhibitors targeting metallo-β-lactamases and indoleamine/tryptophan 2,3-dioxygenases
Qingqing Dai et al.
ACTA PHARMACEUTICA SINICA B (2021)
Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria
Glen T. Hansen
INFECTIOUS DISEASES AND THERAPY (2021)
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections
Bin Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Principles and current strategies targeting metallo-β-lactamase mediated antibacterial resistance
Yu-Hang Yan et al.
MEDICINAL RESEARCH REVIEWS (2020)
Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases
Ruslan Tsivkovski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Antimicrobial Resistance in ESKAPE Pathogens
David M. P. De Oliveira et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance
Jun-ichi Wachino et al.
MBIO (2020)
Metallo-beta-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline
Sara E. Boyd et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Therapeutic Effect and Mechanisms of the Novel Monosulfactam 0073
Ying Sun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
ANT2681: SAR Studies Leading to the Identification of a Metallo-ß-lactamase Inhibitor with Potential for Clinical Use in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae
David T. Davies et al.
ACS INFECTIOUS DISEASES (2020)
Defining new chemical space for drug penetration into Gram-negative bacteria
Shibin Zhao et al.
NATURE CHEMICAL BIOLOGY (2020)
Discovery of mercaptopropanamide-substituted aryl tetrazoles as new broad-spectrum metallo-β-lactamase inhibitors
Yu-Hang Yan et al.
RSC ADVANCES (2020)
Updates on the pathogenicity status of Pseudomonas aeruginosa
Mohd W. Azam et al.
DRUG DISCOVERY TODAY (2019)
Interplay between β-lactamases and new β-lactamase inhibitors
Karen Bush et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Will morphing boron-based inhibitors beat the β-lactamases?
Alen Krajnc et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Structure-Based Development of (1-(3'-Mercaptopropanamido)methyl)boronic Acid Derived Broad Spectrum, Dual-Action Inhibitors of Metallo- and Serine-β-lactamases
Yao-Ling Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases
Alen Krajnc et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Crystal structures of VIM-1 complexes explain active site heterogeneity in VIM-class metallo-β-lactamases
Ramya Salimraj et al.
FEBS JOURNAL (2019)
SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model
Simon Leiris et al.
ACS INFECTIOUS DISEASES (2019)
Game Changers: New β-Lactamase Inhibitor Combinations Targeting Antibiotic Resistance in Gram-Negative Bacteria
Karen Bush
ACS INFECTIOUS DISEASES (2018)
((S)-3-Mercapto-2-methylpropanamido)acetic acid derivatives as metallo-β-lactamase inhibitors: Synthesis, kinetic and crystallographic studies
Sha Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics
Zhizeng Sun et al.
NATURE COMMUNICATIONS (2018)
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-beta-Lactamase Inhibitor Combinations
George G. Zhanel et al.
DRUGS (2018)
Predictive compound accumulation rules yield a broad - spectrum antibiotic
Michelle F. Richter et al.
NATURE (2017)
NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors
Guo-Bo Li et al.
CHEMICAL SCIENCE (2017)
A general reaction mechanism for carbapenem hydrolysis by mononuclear and binuclear metallo-β-lactamases
Maria-Natalia Lisa et al.
NATURE COMMUNICATIONS (2017)
The road to avibactam: the first clinically useful non-β-lactam working somewhat like a β-lactam
David Yuxin Wang et al.
FUTURE MEDICINAL CHEMISTRY (2016)
New β-Lactamase Inhibitors in the Clinic
Krisztina M. Papp-Wallace et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes
Philip Hinchliffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates
Juergen Brem et al.
NATURE COMMUNICATIONS (2016)
Are the physicochemical properties of antibacterial compounds really different from other drugs?
Jean-Paul Ebejer et al.
JOURNAL OF CHEMINFORMATICS (2016)
Relative Strengths of Promoters Provided by Common Mobile Genetic Elements Associated with Resistance Gene Expression in Gram-Negative Bacteria
Muhammad Kamruzzaman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase
Mariano M. Gonzalez et al.
ACS INFECTIOUS DISEASES (2015)
Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability
Anne Makena et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
X-ray crystallographic analysis of IMP-1 metallo-β-lactamase complexed with a 3-aminophthalic acid derivative, structure-based drug design, and synthesis of 3,6-disubstituted phthalic acid derivative inhibitors
Yukiko Hiraiwa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Trends and Exceptions of Physical Properties on Antibacterial Activity for Gram-Positive and Gram-Negative Pathogens
Dean G. Brown et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Assay Platform for Clinically Relevant Metallo-β-lactamases
Sander S. van Berkel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Periplasmic production via the pET expression system of soluble, bioactive human growth hormone
Jonathan T. Sockolosky et al.
PROTEIN EXPRESSION AND PURIFICATION (2013)
The emerging NDM carbapenemases
Patrice Nordmann et al.
TRENDS IN MICROBIOLOGY (2011)
A structural view of the antibiotic degradation enzyme NDM-1 from a superbug
Yu Guo et al.
PROTEIN & CELL (2011)
Updated Functional Classification of beta-Lactamases
Karen Bush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
New beta-lactam antibiotics and beta-lactamase inhibitors
Karen Bush et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices
James H. Jorgensen et al.
CLINICAL INFECTIOUS DISEASES (2009)
Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa
Todd A. Davies et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Physicochemical properties of antibacterial compounds: Implications for drug discovery
Rosemarie O'Shea et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Comparative review of the carbapenems
George G. Zhanel et al.
DRUGS (2007)
Antibiotic recognition by binuclear metallo-β-lactamases revealed by X-ray crystallography
J Spencer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Share Paper
